Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Results from a preclinical study in mice and a collaborative clinical study in patients show that the type 2 immune response -- associated with parasitic infection and thought to play a negative role ...

Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and business highlights Total H1 2024 incomes of €82.5 million thanks to Company's new partnerships.Ne ...

From a recent study by Mayo Clinic, discover how preoperative radiotherapy could improve survival rates for glioblastoma ...

Crohn's disease—an autoimmune disorder—is characterized by chronic inflammation of the digestive tract, resulting in a slew ...

NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

Amber Bennett-Weston and colleagues argue that greater patient involvement would benefit both patients and doctors Historically, patients were “wheeled in” to lecture theatres, often without consent, ...